Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

γc-Signaling Cytokines Induce a Regulatory T Cell Phenotype in Malignant CD4+ T Lymphocytes
Monika Kasprzycka, Qian Zhang, Agnieszka K. Witkiewicz, et al.
The Journal of Immunology (2008) Vol. 181, Iss. 4, pp. 2506-2512
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
Michał Marzec, Qian Zhang, Ami Goradia, et al.
Proceedings of the National Academy of Sciences (2008) Vol. 105, Iss. 52, pp. 20852-20857
Open Access | Times Cited: 662
PLCG1 mutations in cutaneous T-cell lymphomas
José P. Vaqué, Gonzalo Gómez‐López, V. Monsálvez, et al.
Blood (2014) Vol. 123, Iss. 13, pp. 2034-2043
Open Access | Times Cited: 216
Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2017) Vol. 92, Iss. 10, pp. 1085-1102
Open Access | Times Cited: 141
Cutaneous T‐cell lymphoma: 2016 update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 151-165
Open Access | Times Cited: 139
Malignant inflammation in cutaneous T‐cell lymphoma—a hostile takeover
Thorbjørn Krejsgaard, Lise M. Lindahl, Nigel P. Mongan, et al.
Seminars in Immunopathology (2016) Vol. 39, Iss. 3, pp. 269-282
Open Access | Times Cited: 129
Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma
Andreas Willerslev-Olsen, Thorbjørn Krejsgaard, Lise M. Lindahl, et al.
Blood (2016) Vol. 127, Iss. 10, pp. 1287-1296
Open Access | Times Cited: 99
Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma
Anjali Mishra, Krista La Perle, Sonya Kwiatkowski, et al.
Cancer Discovery (2016) Vol. 6, Iss. 9, pp. 986-1005
Open Access | Times Cited: 87
Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment
Xinrui Zhang, Pham Ngoc Chien, Sun‐Young Nam, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1650-1650
Open Access | Times Cited: 44
Expression Patterns of the Immunosuppressive Proteins PD-1/CD279 and PD-L1/CD274 at Different Stages of Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Kanchan Kantekure, Yusong Yang, Puthiyaveettil N. Raghunath, et al.
American Journal of Dermatopathology (2011) Vol. 34, Iss. 1, pp. 126-128
Open Access | Times Cited: 109
Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome
Thorbjørn Krejsgaard, Niels Ødum, Carsten Geisler, et al.
Leukemia (2011) Vol. 26, Iss. 3, pp. 424-432
Closed Access | Times Cited: 107
Malignant Cutaneous T-Cell Lymphoma Cells Express IL-17 Utilizing the Jak3/Stat3 Signaling Pathway
Thorbjørn Krejsgaard, Ulrik Ralfkiær, Erik Clasen‐Linde, et al.
Journal of Investigative Dermatology (2011) Vol. 131, Iss. 6, pp. 1331-1338
Open Access | Times Cited: 104
The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL‐10 expression in cutaneous T‐cell lymphoma cells
CE Tiffon, J E Adams, Leslie van der Fits, et al.
British Journal of Pharmacology (2010) Vol. 162, Iss. 7, pp. 1590-1602
Open Access | Times Cited: 92
Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell Lymphoma
Andreas Willerslev-Olsen, Thorbjørn Krejsgaard, Lise M. Lindahl, et al.
Toxins (2013) Vol. 5, Iss. 8, pp. 1402-1421
Open Access | Times Cited: 84
Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target
Michael T. Werner, Chen Zhao, Qian Zhang, et al.
Blood (2016) Vol. 129, Iss. 7, pp. 823-831
Open Access | Times Cited: 82
Cutaneous T‐cell lymphoma: 2014 Update on diagnosis, risk‐stratification, and management
Ryan A. Wilcox
American Journal of Hematology (2014) Vol. 89, Iss. 8, pp. 837-851
Open Access | Times Cited: 67
The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL)
Ivonne A. Montes‐Mojarro, Julia Steinhilber, Irina Bonzheim, et al.
Cancers (2018) Vol. 10, Iss. 4, pp. 107-107
Open Access | Times Cited: 62
Humanization of an Anti-CCR4 Antibody That Kills Cutaneous T-Cell Lymphoma Cells and Abrogates Suppression by T-Regulatory Cells
De-Kuan Chang, Jianhua Sui, Shusheng Geng, et al.
Molecular Cancer Therapeutics (2012) Vol. 11, Iss. 11, pp. 2451-2461
Open Access | Times Cited: 72
FOXP3+CD25− Tumor Cells with Regulatory Function in Sézary Syndrome
Julia B. Heid, Angelika Schmidt, Nina Oberle, et al.
Journal of Investigative Dermatology (2009) Vol. 129, Iss. 12, pp. 2875-2885
Open Access | Times Cited: 70
Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation
Thorbjørn Krejsgaard, Andreas Willerslev-Olsen, Lise M. Lindahl, et al.
Blood (2014) Vol. 124, Iss. 5, pp. 761-770
Open Access | Times Cited: 65
Tumor microenvironment in mycosis fungoides and Sézary syndrome
Belén Rubio González, Jasmine Zain, Steven T. Rosen, et al.
Current Opinion in Oncology (2015) Vol. 28, Iss. 1, pp. 88-96
Closed Access | Times Cited: 58
Benign T cells drive clinical skin inflammation in cutaneous T cell lymphoma
Pablo Vieyra-Garcia, Jack D. Crouch, John T. O’Malley, et al.
JCI Insight (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 51
The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma
Ronnie M. Abraham, Qian Zhang, Niels Ødum, et al.
Cancer Biology & Therapy (2011) Vol. 12, Iss. 12, pp. 1019-1022
Open Access | Times Cited: 57
Bortezomib Inhibits Expression of TGF-β1, IL-10, and CXCR4, Resulting in Decreased Survival and Migration of Cutaneous T Cell Lymphoma Cells
Tzu‐Pei Chang, Vladimir Poltoratsky, Ivana Vancurova
The Journal of Immunology (2015) Vol. 194, Iss. 6, pp. 2942-2953
Open Access | Times Cited: 44
Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets
Ieva Saulīte, Wolfram Hoetzenecker, Stephan Weidinger, et al.
BioMed Research International (2016) Vol. 2016, pp. 1-15
Open Access | Times Cited: 40
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines
Maria Cosenza, Monica Civallero, Stefania Fiorcari, et al.
Cancer Biology & Therapy (2016) Vol. 17, Iss. 10, pp. 1094-1106
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top